Trials / Completed
CompletedNCT00803127
VS-Sense Result Reading Clarity
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (estimated)
- Sponsor
- Carmel Medical Center · Academic / Other
- Sex
- Female
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
This study is designed to demonstrate the result reading clarity of the VS-SENSE is substantially equivalent to the result reading clarity of the Nitrazine pH Paper test for vaginal secretions.
Detailed description
Once informed consent has been signed, the clinician will perform the following: Record baseline variables in the CRF. The 1st clinician will obtain a vaginal secretion sample by using the VS-SENSE swab. The 1st clinician will obtain the specimen by separating the labia to expose the vagina. The yellow tip of the VS-SENSE swab will be inserted into the vagina approximately 5 cm/ 2". The 1st clinician will use the VS-SENSE according the instructions for use - attachment 1 to the protocol. The 1st clinician will read the VS-SENSE results and record them on the designated form (Clinician Report - VS-SENSE Result form), and fill out the table regarding the VS-SENSE reading clarity on the same form.Vaginal examination (including speculum examination) - will be performed by a 2nd clinician, masked from the results of the 1st clinician test. The 2nd clinician will use a vaginal swab for pH measurement by Nitrazine pH Paper test. The Nitrazine pH Paper test will be performed according to strict manufacturer's instruction. The 2nd clinician will read the results of the Nitrazine pH Paper test result, document it on the Clinician Report - pH Test Result form, and fill out the table regarding the pH test reading clarity on the same form.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | vs-sense | detection swab |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2009-04-01
- Completion
- 2009-05-01
- First posted
- 2008-12-05
- Last updated
- 2009-08-11
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00803127. Inclusion in this directory is not an endorsement.